Elanco Animal Health Inc (ELAN): Cash & Equivalents
$545.00M
As of 2025-12-31
$530.00M
As of 2026-06-30
+16.5%
3-year compound annual growth
+1.9%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $545.00M | +16.5% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $468.00M | +33.0% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $352.00M | +2.0% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $345.00M | -45.9% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $638.00M | +28.9% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $495.00M | +48.2% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $334.00M | -29.7% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $474.80M | +46.8% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $323.40M | n/a | 2020-02-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $545.00M | +16.5% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.39B | -42.3% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.55B | +73.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.66B | +71.5% |
| Organon & Co. (OGN) | 2025-12-31 | $574.00M | -15.0% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.31B | +39.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.56B | -8.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $282.03M | +155.1% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $618.70M | -33.4% |
Compare ELAN, JAZZ, ONC, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗